BORAY vs JNJ: Which Is the Better Dividend Stock?
As of September 2026, BORAY (Bora Pharmaceuticals Co., Ltd.) screens as the stronger dividend stock, winning 3 of 5 head-to-head metrics. BORAY offers the higher yield at 2.00%, JNJ has the higher dividend-safety score, and BORAY trades at the larger discount to fair value (+13%).
| Metric | BORAY | JNJ |
|---|---|---|
| Forward yield | 2.00% | 1.99% |
| Annual dividend | $0.06 | $5.36 |
| Payout ratio | 0% | 61% |
| Years of growth | 0 yr | 55 yr |
| 5-yr dividend growth | — | 5.2% |
| 5-yr total return | — | 66% |
| Dividend safety score | — | 93 (A) |
| Fair value estimate | $3.55 | $240.60 |
| Upside to fair value | +13% | -11% |
| Frequency | weekly | quarterly |
| Market cap | $400.6M | $649.4B |
| P/E ratio | 7.8 | 31.3 |
Higher yield
BORAY
2.00%
Safer dividend
JNJ
Grade A
Faster growth
JNJ
5.2%
Better value
BORAY
+13% upside
BORAY vs JNJ — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.